Evidence-Based Medicine Guidelines
Pharmacotherapy for hyperuricemia in hypertensive patients
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Pharmacotherapy for Hyperuricemia in Hypertensive Patients." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/457722/all/Pharmacotherapy_for_hyperuricemia_in_hypertensive_patients.
Pharmacotherapy for hyperuricemia in hypertensive patients. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/457722/all/Pharmacotherapy_for_hyperuricemia_in_hypertensive_patients. Accessed April 3, 2025.
Pharmacotherapy for hyperuricemia in hypertensive patients. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/457722/all/Pharmacotherapy_for_hyperuricemia_in_hypertensive_patients
Pharmacotherapy for Hyperuricemia in Hypertensive Patients [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 April 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/457722/all/Pharmacotherapy_for_hyperuricemia_in_hypertensive_patients.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Pharmacotherapy for hyperuricemia in hypertensive patients
ID - 457722
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/457722/all/Pharmacotherapy_for_hyperuricemia_in_hypertensive_patients
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
